NCT07207564 Integrating Molecular Pathology, Radiology, and Genetics to Improve Breast Cancer Risk
| NCT ID | NCT07207564 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | Breast Carcinoma |
| Study Type | OBSERVATIONAL |
| Enrollment | 4,500 participants |
| Start Date | 2025-08-28 |
| Primary Completion | 2030-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 4,500 participants in total. It began in 2025-08-28 with a primary completion date of 2030-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this research is to better understand how benign breast diseases might lead to breast cancer, focusing on genetic factors and including a diverse range of participants to improve future diagnosis and treatment.
Eligibility Criteria
Inclusion Criteria: * Female patients, ages 18 to 100 years * Had a benign breast biopsy at Mayo Clinic between 2002-2022 Exclusion Criteria: * All male patients * Prior or concomitant diagnosis of BC * Diagnosis of BC within six months of benign breast disease * Denial of research authorization * Concurrent or post-biopsy bilateral prophylactic mastectomy
Contact & Investigator
Mark E. Sherman, MD
PRINCIPAL INVESTIGATOR
Mayo Clinic
Frequently Asked Questions
Who can join the NCT07207564 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 100 Years, studying Breast Carcinoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07207564 currently recruiting?
Yes, NCT07207564 is actively recruiting participants. Contact the research team at pachecospann.laura@mayo.edu for enrollment information.
Where is the NCT07207564 trial being conducted?
This trial is being conducted at Jacksonville, United States, Rochester, United States.
Who is sponsoring the NCT07207564 clinical trial?
NCT07207564 is sponsored by Mayo Clinic. The principal investigator is Mark E. Sherman, MD at Mayo Clinic. The trial plans to enroll 4,500 participants.